Skip to content
OpenCapital
Get started

Philip Morris International PM Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

Altria Group logo
Altria GroupMO
——

Other financials

Income statement

See full
Revenue$10.1B+9.1%
Gross profit$6.9B+10.1%
Operating income$3.9B+9.8%
Net income$2.4B-9.4%
EPS (diluted)$1.56-9.3%

Balance sheet

See full
Cash & equivalents$5.5B+22.2%
Total debt$52.0B+4.8%
Total equity-$9.3B+14.9%
Total assets$68.9B+5.9%

Cash flow

See full
Operating cash flow-$399.0M-14.0%
CapEx$353.0M-12.6%
Free cash flow-$752.0M+0.3%

Valuation

See full
Market cap$278.05B+4.3%
Enterprise value$324.61B+4.1%
P/E25.1×-7.5×
P/S6.7×-0.2×

Profitability

See full
Gross margin67.3%+1.6pp
Operating margin36.7%+0.5pp
Net margin26.7%+5.4pp
FCF margin25.7%-0.9pp

Returns & leverage

See full
Return on equity-110%—
Debt / equity-5.6×—
Current ratio1×+0.2×

Where this comes from

Reported directly by Philip Morris International in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Philip Morris International’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Philip Morris International's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Philip Morris International's indefinite- lived intangible impairment?
Philip Morris International (PM) reported indefinite- lived intangible impairment of $13.87B in Q1 2026.
How has Philip Morris International's indefinite- lived intangible impairment changed year-over-year?
Philip Morris International's indefinite- lived intangible impairment increased by 1.3% year-over-year, from $13.69B to $13.87B.
What is the long-term trend for Philip Morris International's indefinite- lived intangible impairment?
Over 5 years (2020 to 2025), Philip Morris International's indefinite- lived intangible impairment has grown at a 38.6% compound annual growth rate (CAGR), from $2.74B to $14.01B.